4DMedical enters trading halt ahead of capital raise announcement

The news: Respiratory imaging technology company 4DMedical has entered a trading halt on the ASX pending an announcement about a capital raise.

The context: 4DMedical, which has seen its shares surge more than 700% over the last 12 months, said the trading halt was requested for the purposes of “considering, planning and executing” a capital raise.

The trading halt will remain in place until the earlier of the announcement or start of trading on Thursday.

Last year 4DMedical secured key North American regulatory clearances for its flagship lung imaging technology CT:VQ, enabling commercial deployment across both the US and Canada.